sorafenib has been researched along with 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin in 1 studies
Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (17-(dimethylaminoethylamino)-17-demethoxygeldanamycin) | Trials (17-(dimethylaminoethylamino)-17-demethoxygeldanamycin) | Recent Studies (post-2010) (17-(dimethylaminoethylamino)-17-demethoxygeldanamycin) |
---|---|---|---|---|---|
6,520 | 730 | 5,251 | 255 | 9 | 168 |
Protein | Taxonomy | sorafenib (IC50) | 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (IC50) |
---|---|---|---|
Lysine-specific demethylase 6B | Homo sapiens (human) | 0.4 | |
Lysine-specific demethylase 4B | Homo sapiens (human) | 0.7 | |
Heat shock protein HSP 90-alpha | Homo sapiens (human) | 0.1699 | |
Heat shock protein HSP 90-beta | Homo sapiens (human) | 0.2724 | |
5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.0036 | |
Lysine-specific demethylase 5A | Homo sapiens (human) | 0.13 | |
Hypoxia-inducible factor 1-alpha | Homo sapiens (human) | 0.043 | |
Endothelial PAS domain-containing protein 1 | Homo sapiens (human) | 0.0335 | |
Lysine-specific demethylase 4C | Homo sapiens (human) | 0.7 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blay, JY; Dumont, AG; Dumont, SN; Reynoso, D; Trent, JC; Yang, D | 1 |
1 other study(ies) available for sorafenib and 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin
Article | Year |
---|---|
Targeted polytherapy in small cell sarcoma and its association with doxorubicin.
Topics: Apoptosis; Benzoquinones; Cell Cycle; Cell Line, Tumor; Doxorubicin; Humans; Hydroxamic Acids; Lactams, Macrocyclic; Niacinamide; Phenylurea Compounds; Sarcoma, Small Cell; Sorafenib; Vorinostat | 2014 |